Nuvation Bio在2025年世界肺癌大会上公布Ibtrozi™(Taletrectinib)治疗晚期ROS1阳性非小细胞肺癌关键临床研究的最新数据

美股速递
Sep 07

Nuvation Bio在2025年世界肺癌大会上公布Ibtrozi™(Taletrectinib)治疗晚期ROS1阳性非小细胞肺癌关键临床研究的最新数据

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10